0001628280-23-020562.txt : 20230602 0001628280-23-020562.hdr.sgml : 20230602 20230601182518 ACCESSION NUMBER: 0001628280-23-020562 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230601 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230602 DATE AS OF CHANGE: 20230601 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PROCEPT BioRobotics Corp CENTRAL INDEX KEY: 0001588978 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 260199180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40797 FILM NUMBER: 23986075 BUSINESS ADDRESS: STREET 1: 900 ISLAND DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 650-232-7200 MAIL ADDRESS: STREET 1: 900 ISLAND DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94065 8-K 1 prct-20230601.htm 8-K prct-20230601
0001588978false00015889782023-04-282023-04-28

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 1, 2023
PROCEPT BIOROBOTICS CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 001-40797 26-0199180
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification Number)
900 Island Drive
Redwood City, California 94065
(Address of principal executive offices, including Zip Code)
Registrant’s telephone number, including area code: (650) 232-7200
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class 
Trading
Symbol(s)
 
Name of each exchange
on which registered
Common Stock, $0.00001 par value per share PRCT The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐



Item 1.01. Entry into a Material Definitive Agreement.
On June 1, 2023, PROCEPT BioRobotics Corporation (the “Company”) entered into a First Amendment (the “Amendment”) to the Loan and Security Agreement, dated as of October 6, 2022, by and between the Company and Canadian Imperial Bank of Commerce (the “Existing Loan Agreement” and including the Amendment, the “Loan Agreement”).

The Amendment, among other things, modifies the terms of the Existing Loan Agreement to: (1) lower the Company's obligation to maintain in deposit accounts held at CIBC the lesser of (i) $90.0 million or (ii) all of its non-operating cash and (2) allow Company to maintain cash or cash equivalents in excess of that amount with other financial institutions.

Other than as set forth above, the Loan Agreement continues to be subject to the same affirmative covenants and negative covenants as previously disclosed.

The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information set forth in Item 1.01 is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.
(d) Exhibits



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
PROCEPT BIOROBOTICS CORPORATION
Date: June 1, 2023
By:
/s/ Alaleh Nouri
Alaleh Nouri
EVP, Chief Legal Officer and Secretary

EX-10.1 2 firstamendmenttocibcloanam.htm EX-10.1 Document

FIRST AMENDMENT TO
LOAN AND SECURITY AGREEMENT
This First Amendment to Loan and Security Agreement is entered into as of June 1, 2023, (the “Amendment”) is entered into between CANADIAN IMPERIAL BANK OF COMMERCE (“Bank”) and PROCEPT BIOROBOTICS CORPORATION, a Delaware corporation (“Borrower Representative”).
RECITALS
1.Borrower and Bank are parties to that certain Loan and Security Agreement, dated as of October 6, 2022, (as amended from time to time, the “Agreement”).
2.The parties desire to amend the terms of the Agreement as set forth in this Amendment.
AGREEMENT
NOW, THEREFORE, the parties agree as follows:
1.Definitions. Capitalized terms used but not defined in this Amendment shall have the respective meanings given to them in the Agreement.
2.Amendments.
2.aSection 6.6(b) of the Agreement is amended to read as follows:
(b)    The Loan Parties shall maintain the lesser of (x) $90,000,000 in cash and (y) all cash of the Loan Parties in Deposit Accounts that are demand deposit accounts or money market deposit accounts held at CIBC. Subject to Section 6.6(c), the Loan Parties may maintain cash and Cash Equivalents in excess of that amount in Collateral Accounts with an institution, and subject to an Account Control Agreement, reasonably acceptable to Bank (it being agreed that Wells Fargo shall be reasonably acceptable to Bank).
2.bThe last sentence of Section 6.6 of the Agreement is hereby deleted in its entirety.
3.Limitation of Amendments. The Amendments set forth in Section 2 above, are effective for the purposes set forth herein and shall be limited precisely as written and shall not be deemed to (a) be a consent to any amendment, waiver or modification of any other term or condition of any Loan Document, or (b) otherwise prejudice any right or remedy which Bank may now have or may have in the future under or in connection with any Loan Document. Except as modified by this Amendment, the Loan Documents remain in full force and effect and are hereby reaffirmed.
4.Representations. To induce Bank to enter into this Amendment, each Loan Party represents and warrants as follows:
4.aThe representations and warranties contained in the Agreement and the other Loan Documents, are true and correct in all material respects as of the date of this Amendment (except for such representations and warranties referring to another date, which representations and warranties are true and correct in all material respects as of such date).
4.bNo Event of Default has occurred and is continuing.
4.cEach Loan Party has the power and authority to execute and deliver this Amendment and to perform its obligations under the Agreement, as amended by this Amendment.
5.Conditions. As a condition to the effectiveness of this Amendment, Bank shall have received the following:
(i) this Amendment, duly executed by the Loan Parties and Bank; and
(ii) all reasonable and documented Bank Expenses incurred in connection with this Amendment.



6.Counterparts; Electronic Execution of Documents. This Amendment may be executed in any number of counterparts and by different parties on separate counterparts, each of which, when executed and delivered, is an original, and all taken together, constitute one Agreement. Delivery of an executed counterpart of a signature page of this Amendment or any document delivered in connection therewith by electronic means including by email delivery of a “.pdf” format data file shall be effective as delivery of an original executed counterpart thereof.
7.Choice of Law, Venue and Jury Trial Waivers. The provisions of Section 11 of the Agreement are hereby incorporated into this Amendment as if fully set forth herein, mutatis mutandis.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]





[SIGNATURE PAGE TO FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT]
IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed as of the first date above written.
BORROWER REPRESENTATIVE:
PROCEPT BIOROBOTICS CORPORATION
By: /s/ Kevin Waters
Name: Kevin Waters
Title: Chief Financial Officer
BANK:
CANADIAN IMPERIAL BANK OF COMMERCE
By: /s/ Jeff Chapman
Name: Jeff Chapman
Title: Assistant General Manager
By: /s/ Corey Perlmutter
Name: Corey Perlmutter
Title: Assistant General Manager

EX-101.SCH 3 prct-20230601.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 prct-20230601_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Trading Symbol Trading Symbol Entity File Number Entity File Number Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Soliciting Material Soliciting Material Entity Address, City or Town Entity Address, City or Town Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Local Phone Number Local Phone Number Entity Address, Postal Zip Code Entity Address, Postal Zip Code Written Communications Written Communications City Area Code City Area Code Cover [Abstract] Title of 12(b) Security Title of 12(b) Security Document Type Document Type Amendment Flag Amendment Flag Security Exchange Name Security Exchange Name Entity Registrant Name Entity Registrant Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Address, State or Province Entity Address, State or Province Document Period End Date Document Period End Date Pre-commencement Tender Offer Pre-commencement Tender Offer EX-101.PRE 5 prct-20230601_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover Page
Apr. 28, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date Jun. 01, 2023
Entity Registrant Name PROCEPT BIOROBOTICS CORPORATION
Entity Incorporation, State or Country Code DE
Entity File Number 001-40797
Entity Tax Identification Number 26-0199180
Entity Address, Address Line One 900 Island Drive
Entity Address, City or Town Redwood City
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94065
City Area Code 650
Local Phone Number 232-7200
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.00001 par value per share
Trading Symbol PRCT
Security Exchange Name NASDAQ
Entity Central Index Key 0001588978
Amendment Flag false
Entity Emerging Growth Company false
XML 7 prct-20230601_htm.xml IDEA: XBRL DOCUMENT 0001588978 2023-04-28 2023-04-28 0001588978 false 8-K 2023-06-01 PROCEPT BIOROBOTICS CORPORATION DE 001-40797 26-0199180 900 Island Drive Redwood City CA 94065 650 232-7200 false false false false Common Stock, $0.00001 par value per share PRCT NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 22 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.procept-biorobotics.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports prct-20230601.htm firstamendmenttocibcloanam.htm prct-20230601.xsd prct-20230601_lab.xml prct-20230601_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "prct-20230601.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 22 }, "contextCount": 1, "dts": { "inline": { "local": [ "prct-20230601.htm" ] }, "labelLink": { "local": [ "prct-20230601_lab.xml" ] }, "presentationLink": { "local": [ "prct-20230601_pre.xml" ] }, "schema": { "local": [ "prct-20230601.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "prct", "nsuri": "http://www.procept-biorobotics.com/20230601", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "prct-20230601.htm", "contextRef": "i4a38c6cc4e99444d8afda61397aba492_D20230428-20230428", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover Page", "menuCat": "Cover", "order": "1", "role": "http://www.procept-biorobotics.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "prct-20230601.htm", "contextRef": "i4a38c6cc4e99444d8afda61397aba492_D20230428-20230428", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.procept-biorobotics.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.procept-biorobotics.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.procept-biorobotics.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.procept-biorobotics.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.procept-biorobotics.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.procept-biorobotics.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.procept-biorobotics.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.procept-biorobotics.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.procept-biorobotics.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.procept-biorobotics.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.procept-biorobotics.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.procept-biorobotics.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.procept-biorobotics.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.procept-biorobotics.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.procept-biorobotics.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.procept-biorobotics.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.procept-biorobotics.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.procept-biorobotics.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.procept-biorobotics.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.procept-biorobotics.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.procept-biorobotics.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.procept-biorobotics.com/role/CoverPage" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0001628280-23-020562-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001628280-23-020562-xbrl.zip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end